• News

    LRP4: A new bone anabolic drug target? Blog Post from ASBMR Scientific Web Editor Joe Lorenzo

    Date: January 06, 2015

    In his latest blog post, ASBMR Scientific Web Editor Joe Lorenzo, M.D., discusses bone anabolic agents to treat osteoporosis.  He addresses LRP4 levels and its relation to osteoblasts and osteocytes, as a binding protein. Read his full blog post here.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Policies and Procedures for more details